Eloxx Pharmaceuticals (ELOX) Financial Statements

Eloxx Pharmaceuticals's market cap is currently $330.00. The company's EPS TTM is $-9.062; its P/E ratio is ―; Eloxx Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.